Our Faculty is led by stem cell scientist Walter P. Drake, Professor of Stem Cell Medicine, who has been studying the stem cell field for 25 years and is an expert in the field. CV 2025 Walter P Drake
Stem Cell Therapeutics Publications
by
Walter P. Drake
Featured paper
in Stem Cell Medicine
authored by Walter P. Drake:
“High Dose Light Activated PRP the New Stem Cell Therapy”.
In this report issued in June 2023, Dr. Drake and colleague Dr. Laurence Hicks D.O. were possibly the first to describe the entire protocol for Intravenous High Dose Light Activated PRP Therapy. Although parts of the procedure were known, most if not all practitioners were focused in injecting low dose PRP for facial rejuvenation and joint repair. Almost no one was even vaguely thinking about Intravenous Platelet Rich Plasma, or the fact that it would become to be shown to be the pre-eminent therapeutic protocol that would surpass results using other stem cell modalities that had been developed internationally for over 20 years.
The paper includes the drawing depicting the procedure which begins by the collection of blood from a patient, and proceeds to concentrating the platelets by centrifugation, followed by the necessary light activation to release growth factors prior to re-injection back to the patient in about 1 hour:
Since 2023, we now have a wide selection of FDA approved kits which allow for complete sterile, closed system processing of the patient’s PRP so as to avoid contamination. In addition, since that time, we now have additional reports have been published by others detailing the necessity of light activation of the platelets and associated small bodies so as to release the maximum amount of growth factors to wake up innate but dormant stem cells.
The full original report is Here for viewing or downloading:
Intravenous High Dose Light Activated PRP Therapy
Other papers within the stem cell field are shown. Please click on the GOLD Links to View or Download.
November, 2017: Safety Analysis of Autologous Stem Cell Therapy in a Variety of Degenerative Diseases and Injuries Using the Stromal Vascular Fraction, being the first paper published in the United States demonstrating stem cell therapy safety, using stem cells harvested from patients’ abdominal fat and transplanted back into the same patients with various medical conditions.
January, 2022: From a Tube of Blood To Exosomes…The Stem Cell Therapy Story 2022 being the Address to Graduate Students of the Panama College of Cell Science detailing the history of stem cell therapeutics from 2005 to 2022.
January, 2023: Stem Cell Therapy Without Stem Cells, concluding that since stem cells are resident in virtually every tissue and organ, the patient does not need any more stem cells. What the patient needs is the stimulation and activation of endogenous growth factors and cytokines that can come about from the in vivo stimulation by one or more means. Liposuction is just one means of injury, that most likely by itself, is causing the activation of innate stem cells without any need for re-injection of more autologous stem cells.
January, 2023: “Drake-Hicks Protocol For In Situ Release of Mesenchymal Stem Cells and Cytokines Following Abdominal Lipolysis”, discussing methodologies for melting abdominal fatty tissue in vivo by injection and other techniques so as to release stem cells from the fatty matrix into the general circulation, thus avoiding a mini-liposuction.
June, 2023: Intravenous High Dose Light Activated PRP Therapy, noted above, which reviewed the then recent papers demonstrating therapeutic results following high does intravenous therapy with the patient’s platelet rich plasma (PRP) and detailing the appropriate protocol.
January, 2024: “Testing For Inflammatory Markers Associated With Most Diseases Treatable with Stem Cell Therapy”, indicating that the effectiveness of any stem cell therapeutic application could be shown to be effective by testing for relatively common inflammatory markers of serious medical conditions and disease.
November, 2024: “Application of Etaluma Immunofluorescence Microscope for Saliva Protein Analysis”, describing how the effectiveness of stem cell therapies could be exhibited by the quantitative testing of saliva growth factors and cytokines with fluorescent antibodies using the Etaluma immunofluorescence Microscope.
All Biomedical Publications
by
Walter P. Drake
A chronological collection of published biomedical research by Walter P. Drake, N.D., Ph.D., spanning over five decades and covering topics including tumor immunology, stem cell therapy, PRP protocols, and innovative methodologies in regenerative medicine:
Walter P Drake Bibliography May 2025
Additional Teaching Faculty
From time to time applicants inquire about our teaching faculty. As for day to day operations, we have moved away from the use of a part-time faculty panel to a few full time core faculty and instructors which serve as mentors and guides and monitor the students’ progress through the program. Additionally, we rely on learned experts who have generously made their lectures and knowledge available to the world online. So, through the use of video lectures and other online resources, our courses are “taught” by world-renowned experts, lecturers, and authors. Our in-house faculty members serve primarily in the roles of Mentors and Advisors, answer questions, and generally supervise the course content. In this way, we can offer lectures and content both from our “in house” Faculty, as well as from qualified faculty from other international institutions like the Howard Hughes Medical Institute. Such scientist are not on our staff nor associated with us but become our faculty indirectly through their courses and lectures shared with the world online.
Panama College of Cell Science 